Ccnk - cyclin K

Predicted to enable cyclin-dependent protein serine/threonine kinase activator activity; protein kinase binding activity; and protein serine/threonine kinase activity. Predicted to be involved in negative regulation by host of viral genome replication; positive regulation of DNA-templated transcription, elongation; and positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues. Predicted to act upstream of or within cellular response to DNA damage stimulus; in utero embryonic development; and negative regulation of stem cell differentiation. Predicted to be located in nucleoplasm. Predicted to be part of cyclin K-CDK12 complex; cyclin K-CDK13 complex; and cyclin/CDK positive transcription elongation factor complex. Predicted to be active in nucleus. Orthologous to human CCNK (cyclin K). [provided by Alliance of Genome Resources, Apr 2022]